Pharmacy distribution business Sigma Healthcare is reportedly finalising a deal to reverse list privately owned Chemist Warehouse on the ASX.
The deal involves Chemist Warehouse acquiring majority control of Sigma, with potential Australian Competition and Consumer Commission-mandated divestments.
Although terms have been reportedly agreed upon, immediate plans to spin out warehouses still need to be implemented.
Sigma requested a trading halt today pending a statement on a potential transaction. The company is expected to raise around $350 million to align with Chemist Warehouse's business structure.